Stem Point Capital LP Insmed Inc Transaction History
Stem Point Capital LP
- $401 Billion
- Q4 2024
A detailed history of Stem Point Capital LP transactions in Insmed Inc stock. As of the latest transaction made, Stem Point Capital LP holds 106,610 shares of INSM stock, worth $8.29 Million. This represents 1.84% of its overall portfolio holdings.
Number of Shares
106,610Holding current value
$8.29 Million% of portfolio
1.84%Shares
4 transactions
Others Institutions Holding INSM
# of Institutions
498Shares Held
189MCall Options Held
3.21MPut Options Held
2.72M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.42 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.11 Billion0.02% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y913MShares$1.01 Billion84.75% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.7MShares$988 Million0.1% of portfolio
-
Capital International Investors Los Angeles, CA7.12MShares$553 Million0.1% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $10.5B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...